WALTHAM, Mass., Jan. 3, 2012 (GLOBE NEWSWIRE) -- ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that its presentation at the J.P. Morgan 30th Annual Healthcare Conference at 2:00 pm PT on January 10, 2012 will be webcast live.
